The A(H5N1) virus generally causes mild illness of short duration, mainly among US adults exposed to infected animals.

Vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, while confidence in other vaccines remains unchanged.

Emergency department physicians show wide variability in their admission propensity, despite seeing patients with similar prior health status.

The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

Long COVID prevalence and burden continue to decrease among health care workers however, some still experience everyday life restrictions.

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

Patients with autosomal dominant polycystic kidney disease and their clinicians need to be alert for diabetes, infection, and clotting.

COVID-19 is associated with accelerated decline in kidney function, especially after hospitalization, according to study findings.

Norovirus is surging across the United States this winter, according to the latest data from the U.S. Centers for Disease Control and Prevention. The data show 91 outbreaks of norovirus during the ...

President Biden signed the Cardiomyopathy HEARTS Act into law, ensuring students in schools throughout the US are better prepared to save the life of a cardiac arrest victim.

Implementation of e-visit billing for responding to patient-initiated messages that require substantive medical decision-making is associated with a modest decrease in patient-initiated portal message ...

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for severe RSV disease.